baber/WOPTO huggingface dataset:
Patent AU-2021325826-B2 (AU)
Title: System and method for global synchronization of time in a distributed processing environment
Inventor: BISMUTH ROBERT
IPC: G01S19/11
Filed: 2021-07-22
Granted: 2023-11-23
Abstract: A system and method employing a precisely synchronized time in connection with a distributed hardware architecture are disclosed. Using an independent and trusted time signal and a second transition pulse signal, each resource in the distributed hardware architecture may be synchronized precisely to the same absolute time. Methods are disclosed wherein the using the precision oscillator signal comprises utilizing a local oscillator to produce a local clock signal at the local system clock frequency. In some implementations, the identifying a trusted time signal and a pulse per second signal comprises identifying a satellite signal; such as a global positioning system signal.
Patent AU-2022203331-B2 (AU)
Title: Multiplexing control information in a physical uplink data channel
Inventor: PAPASAKELLARIOU ARIS
IPC: H04L1/00
Filed: 2022-05-17
Granted: 2023-04-13
Abstract: Methods and apparatuses for multiplexing control information in a physical 
uplink data channel. A method of a user equipment (UE) includes receiving a 
5 configuration for a first set of values and receiving a downlink control information 
(DCI) format scheduling a transmission of a physical uplink shared data channel 
(PUSCH) over a set of resource elements (REs) and including a field providing an 
index. The method further includes determining a first value from the first set of 
values based on the index, determining a first subset of REs from the set of REs, 
10 for multiplexing first uplink control information (UCI), based on the first value, and 
transmitting the first UCI in the PUSCH.
Patent AU-2022204698-B2 (AU)
Title: A high-temperature superconducting qubit and fabrication method
Inventor: POCCIA NICOLA
IPC: H10N60/12
Filed: 2022-06-30
Granted: 2023-11-16
Abstract: A high-temperature superconducting qubit is adapted to implement a quantum mechanical 
two-level system. The high-temperature superconducting qubit comprises a first 
5 superconductor, a second superconductor, and an overlap region. The first superconductor 
comprises a first high-temperature superconductor material comprising a first surface and a 
first orientation. The second superconductor comprises a second high-temperature 
superconductor material comprising a second surface and a second orientation. In the overlap 
region, at least a first section of the first surface and at least a second section of the second 
o surface overlap, the first section and the second section are arranged in parallel at a distance 
corresponding to a predefined distance, and the first orientation and the second orientation 
are arranged with an angle corresponding to a predefined angle. The high-temperature 
superconducting qubit comprises a Josephson junction between the first high-temperature 
superconductor material and the second high-temperature superconductor material. The 
5 Josephson junction is adapted to provide the quantum mechanical two-level system of the 
high-temperature superconducting qubit.  
(Fig. 6A) 
18852461_1 (GHMatters) P119404.AU
12/13 
0 
0 
0 
0e 
00 
'~0 
00 
00 
'~0
Patent JP-3373190-B2 (JP)
IPC: B41F21/00
Filed: 2000-07-04
Granted: 2003-02-04
Abstract: The feeder unit has two symmetrically arranged gripper systems set round a double-sized feeder drum (3) whose axis is mounted on or vertically off-set above a horizontal (24) formed through the axes of all the printing cylinders (5) in the processing units (14-17). Each gripper system is mounted for swivel movement on the drum and has a gripper shaft, several grippers on the shaft, and associated gripper contact strips (2) which have several front markers. Inside the gripper system each gripper has a gripper finger with aperture or recess which when the gripper is closed can be brought into function connection with a front marker.
Patent JP-4136286-B2 (JP)
IPC: C23C2/02
Filed: 2000-07-19
Granted: 2008-08-20
Abstract: The present invention provides a Zn-Al-Mg-Si alloy-plated steel material with excellent corrosion resistance, characterized by comprising, in terms of wt%, Al: at least 45% and no greater than 70%, Mg: at least 1% and less than 5%, Si: at least 0.5% and less than 3%, with the remainder Zn and unavoidable impurities, wherein the Al/Zn ratio is 0.89-2.75 and the plating layer contains a scaly Mg 2 Si phase.
Patent JP-3815217-B2 (JP)
IPC: H04N5/66
Filed: 2000-12-15
Granted: 2006-08-30
Abstract: PROBLEM TO BE SOLVED: To provide a liquid crystal device, a projection type display device and an electronic equipment which attains high-contrast and bright display so that a display defect due to disclination is not generated to a high definition liquid crystal display device in which the interval between pixels is small. SOLUTION: The liquid crystal display device is provided with a liquid crystal layer which is held between a first substrate and a second substrate and first electrodes and second electrodes formed on the surface of the liquid crystal layer side of the second substrate and in which the first electrodes and the second electrodes are constituted so that electric fields which are substantially parallel with the substrates can be applied to the liquid crystal layer. The liquid crystal device has plural areas where directions along which the arrangement of liquid crystal molecules is changed are different in a pixel area formed with the first electrodes and the second electrodes.
Patent JP-4301730-B2 (JP)
IPC: C12P21/04
Filed: 1998-11-06
Granted: 2009-07-22
Abstract: A method of making a glycosylated antibody or antibody fragment having a reactive ketone group on the glycosylated site is provided. The method comprises expressing a cell transfected with a vector encoding an antibody having one or more glycosylation sites in a culture medium comprising a ketone derivative of a saccharide or saccharide precursor and, in the case of an antibody fragment, fragmenting the resulting antibody into an antigen-binding antibody fragment. Methods of making immunoconjugates comprising the glycosylated antibodies or antibody fragments also are provided, wherein the antibody or antibody fragment is reacted with an agent comprising a ketone-reactive group. Glycosylated antibodies and antibody fragments having a reactive ketone group on the glycosylated site, immunoconjugates comprising such antibodies and antibody fragments and in vivo targeting methods using such antibodies, antibody fragments and immunoconjugates also are provided.
Patent JP-4194754-B2 (JP)
IPC: A61B17/20
Filed: 1999-01-05
Granted: 2008-12-10
Abstract: An injector serving for injection of an injection fluid is described. The injector includes a housing with a contact face for during injection supporting on the skin of a person. The injection fluid is placed in a chamber in the housing which furthermore contains an injection needle placed, in a direction of activation intersecting both the at least one chamber and the contact face, displaceably in the housing from a position of rest where the needle point is in front of the at least one chamber-seen in the direction of activation-to an injection position where the point has penetrated the skin. In the point is furthermore made an eye for, at activation of the injector, receiving a fixed quantity of injection fluid during the passage of the chamber, and after this, there is placed a membrane with a slot which during the injection process fits tightly around the needle and thereby sweeps off all fluid except for the fluid in the eye. An injection can be performed with greater easiness, quickness, precision and uniformity than known so far so that a uniform basis for a medical estimate of the type of allergy and the degree of this can be obtained with e.g., an allergy test.
Patent JP-4644368-B2 (JP)
IPC: G09C1/00
Filed: 1999-06-23
Granted: 2011-03-02
Abstract: A technique for generating, for a given message to be signed, an authentic cryptographic signature that can be authenticated, by a recipient of the signed message, as having originated from a signor of the message; and appropriately authenticating such a signature. Specifically, this technique, given a message, such as, e.g., a numerical product copy identifier (83, 93), forms an authentic signature (87, 97), based on public-key cryptosystem, through use of generator value selected from points on an elliptic curve over a finite field. The authentic signature is generated using the generator value in conjunction with three keys; namely, a public key, a private key and a secret key, and thus substantially increases the security associated with cryptographic signatures generated through a conventional two-key public-key cryptosystem. A unique product copy indicia can be formed by concatenating the identifier, for a given product copy, with its corresponding authentic signature. During subsequent user installation of that copy to a computer (200), the user enters the indicia when prompted by execution of an installation program which, in turn, privately authenticates the signature contained in the indicia in order to continue or prematurely terminate the installation.
Patent JP-4362015-B2 (JP)
IPC: A61M39/26
Filed: 1999-10-01
Granted: 2009-11-11
Abstract: A needleless IV injection port assembly includes a spiked body provided with a hollow spike, a female luer component, a flexible and resilient spike boot having a tip and spring portion, a centering member, and a-resilient swabbable septum. The spike boot extends over the spike, the centering member is provided over a portion of the spike and spike boot, and the septum is provided between the centering member and an end of the female luer component. The spiked body and the female luer component are secured together to complete the assembly. The length of the female luer component and/or the length of the spike is chosen so that when a separate male luer is positioned over a protuberance on the septum and pushed into the female luer component, the male luer places pressure upon the septum which thereby urges the septum toward the spike. The pressure on the septum causes the spring portion of the boot to be compressed and the tip portion of the boot to be pierced by the tip of the spike. As the septum is further compressed, the septum extends over the spike, with a pre-slit hole in the septum facilitating the extension thereover, such that a hollow of the spike is in fluid communication with the male luer connector. The injection port causes minimal reflux, and the spike boot and septum provide a swabbable antibacterial double barrier over the spike.
Patent JP-4724299-B2 (JP)
IPC: D21C9/18
Filed: 1999-09-22
Granted: 2011-07-13
Abstract: The present invention relates to the thickening of pulp suspensions. A low consistency pulp suspension is fed to a pre-thickener ( 10 ) through an inlet conduit ( 18 ). A layer of thickened pulp, formed on a filter surface ( 22 ), is pushed along the filter surface by a cleaning member to the discharge end of the pre-thickener and is discharged through the outlet ( 20 ). The cleaning member comprises a rotating shaft ( 30 ), on which shaft at least one screw thread ( 32 ) is fixed so as to leave a free space between the shaft and the screw thread. Essentially non-thickened pulp is allowed to flow through the apparatus via this space.
Patent JP-3593035-B2 (JP)
IPC: A61P11/06
Filed: 1999-10-13
Granted: 2004-11-24
Abstract: Amino-substituted dihydropyrimido[4,5-d]pyrimidinones of the formula in which R1 represents hydrogen, lower alkyl, aryl, aryl-lower alkyl, heteroaryl, heteroaryl-lower alkyl, lower cycloalkyl or lower cycloalkyl-lower alkyl, R2 represents lower alkyl, aryl, aryl-lower alkyl, heteroaryl, heteroaryl-lower alkyl, lower cycloalkyl or lower cycloalkyl-lower alkyl, and R3 represents hydrogen, lower alkyl, aryl, aryl-lower alkyl, heteroaryl, heteroaryl-lower alkyl, lower cycloalkyl, lower cycloalkenyl or lower cycloalkyl-lower alkyl, and pharmaceutically acceptable salts thereof are protein kinase inhibitors. They can be used in the treatment or prophylaxis of inflammatory, immunological, oncological, bronchopulmonary, dermatological and cardiovascular disorders, in the treatment of asthma, central nervous system disorders or diabetic complications or for the prevention of graft rejection following transplant surgery.
Patent JP-3967590-B2 (JP)
IPC: H04J13/00
Filed: 2000-07-13
Granted: 2007-08-29
Abstract: A method for improving performances of a mobile radiocommunication system using a power control algorithm for controlling a transmit power according to a transmission quality target value, and an adjustment algorithm for adjusting said transmission quality target value according to transmission requirements, said method including, upon the occurrence of a change in said transmission requirements, bypassing said adjustment algorithm, by applying a corresponding change to said transmission quality targetvalue, so as to adjust it in an anticipated way.
Patent JP-4695808-B2 (JP)
IPC: B23Q17/24
Filed: 2000-11-17
Granted: 2011-06-08
Abstract: A light source generates a beam of light which is incident on a detector which generates a trigger signal when the beam incident upon it is occluded by a tool. To avoid trigger signals being produced when the beam is temporarily occluded by coolant drips passing through the beam, the detector produces a detection signal each time the beam is occluded, but only produces a trigger signal if a further detection signal is produced in a specified time interval from the generation of an earlier detection signal. Samples of the detection signal are stored in a buffer. When these stored signals indicate a repetitive pattern a trigger signal is issued. <IMAGE>
Patent JP-3588454-B2 (JP)
IPC: B29C48/53
Filed: 2000-09-29
Granted: 2004-11-10
Abstract: An apparatus for pre-processing and subsequent plastification or agglomeration of synthetic plastic materials, in particular thermoplastic waste plastics for recycling purposes, has a receptacle ( 1 ) in which at least one comminuting tool ( 6 ) circulates. The housing ( 7 ) of a screw ( 8 ) is connected to the receptacle ( 1 ). The diameter (D) of the receptacle ( 1 ) has the following relationship to the screw diameter (d): <?in-line-formulae description="In-line Formulae" end="lead"?>D=10.{square root over (K.d<SUP>2</SUP>)}, wherein <?in-line-formulae description="In-line Formulae" end="tail"?> D is the inner diameter of the receptacle in mm, d is the screw diameter in mm and K is a dimension-less constant which amounts to at least 190. Thereby the dwell times of the synthetic plastic material within the receptacle ( 1 ) are kept at optimal values.
Patent JP-4503907-B2 (JP)
IPC: C07D/
Filed: 2002-03-01
Granted: 2010-07-14
Abstract: The present invention is related to novel processes for preparing anhydrous and hydrated forms of piperidine derivatives, polymorphs and pseudomorphs thereof of the formulas   
which are useful as antihistamines, antiallergic agents and bronchodilators.
Patent JP-3597512-B2 (JP)
IPC: G02B1/04
Filed: 2002-03-11
Granted: 2004-12-08
Abstract: A process for releasing leachable substances from a polymeric contact lens blank. The contact lens is confined in a cavity within a carrier to permit the hydration of the lens without permitting it to invert or roll over. A fluid flow is introduced into the cavity about the lens to extract leachable material from the lens. The process significantly reduces the amount of leaching fluid that is used and the amount of time that is needed for hydration, washing and extraction.
Patent JP-3886851-B2 (JP)
IPC: G10L19/02
Filed: 2002-06-07
Granted: 2007-02-28
Abstract: <P>PROBLEM TO BE SOLVED: To provide an audio signal encoding device for removing the cause of sound quality deterioration which occurs when a quantizing noise included in an audio signal is suppressed.  <P>SOLUTION: The device comprises: a prediction gain calculating means 110 for generating a linear prediction coefficient of discrete coefficient information in each frequency at every block, and calculating a prediction gain being the ratio of a linear prediction coefficient level and the level of an error in linear prediction; a threshold determining means 120 for determining whether each calculated prediction gain exceeds a prescribed threshold; a block selecting means 130 for selecting the number of blocks which is not greater than a prescribed number from the objective blocks corresponding to the prediction gain which is judged to exceed the threshold; and a quantizing noise suppressing means 140 for filtering each piece of the discrete coefficient information, suppressing the quantizing noise and generating the signal of a prediction residual difference being a linear prediction error at every block.  <P>COPYRIGHT: (C)2004,JPO
Patent JP-4370552-B2 (JP)
IPC: A61J1/05
Filed: 2002-08-08
Granted: 2009-11-25
Abstract: Chemical agent feed and discharge ports (24,28) are formed at the upper and lower ends of a feeding port assembly (10) in a feed chamber. A dezymotizing filter (16) is in a feed passage (36) communicating with the ports (24,28). A closure (30) closes the feed passage on the downstream side of the filter. The feed chamber and a chemical agent storage chamber are separated by a releasable sealant.
Patent JP-4925549-B2 (JP)
IPC: C07C/
Filed: 2001-06-29
Granted: 2012-04-25
Abstract: The present invention pertains, at least in part, to novel 9- substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Patent JP-4080879-B2 (JP)
IPC: B65H35/00
Filed: 2001-10-23
Granted: 2008-04-23
Abstract: A tape dispenser (10) article is provided wherein the tape dispenser (10) article has a curvilinear tape core with side portions (21). The tape core (22) may have a textured surface. Such a textured surface would permit easy removal of the end of the tape without the addition of a release layer. The core (22) is a grid-like honey-comb wherein the effective tape surface area is defined by the size and number of open cells. The effective surface area provides similar release characteristics as a textured surface.
Patent JP-4308903-B2 (JP)
IPC: B65H23/038
Filed: 2002-04-26
Granted: 2009-08-05
Abstract: A form-fill-seal packaging machine, comprising an apparatus for tracking a web of material in an internal aseptic environment of the packaging machine, the apparatus comprising 
a support member (40), a tracking assembly (36), and an alignment mechanism (38), the tracking assembly (36) having a contact member (58) depending from an engaging member (56), and the contact member (58) being adapted to contact the web of material, wherein the support member (40) is rotatedly connected at an angle to the tracking assembly (36), wherein one of either the support member (40) or the tracking assembly (36) has a first rotation member depending therefrom, and the other of either the support member (40) or the tracking assembly (36) has a mating receptacle, the first rotation member communicating with and rotating within the receptacle, wherein a portion of the engaging surfaces between the first rotation member and the receptacle are sealed from the internal aseptic environment of the packaging machine, and wherein the alignment mechanism (38) is connected to the tracking assembly (36) to control the angle of rotation between the support member (40) and the tracking assembly (36). There is also disclosed a tracking mechanism (36) for a form-fill-seal packaging machine and a container for holding a pharmaceutical.
Patent JP-4414142-B2 (JP)
IPC: C12N5/10
Filed: 2002-05-13
Granted: 2010-02-10
Abstract: The invention relates to specific binding members, particularly antibodies and active fragments thereof, which recognize an aberrant post-translationally modified, particularly an aberrant glycosylated form of the EGFR. The binding members, particularly antibodies and fragments thereof, of the invention do not bind to EGFR on normal cells in the absence of amplification of the wild- type gene and are capable of binding the de2-7 EGFR at an epitope which is distinct from the junctional peptide. Antibodies of this type are exemplified by the novel antibody 806 whose VH and VL sequences are illustrated as SEQ ID Nos: 2 and 4 and chimeric antibodies thereof as exemplified by ch806.
Patent JP-3898137-B2 (JP)
IPC: H04B3/48
Filed: 2003-03-06
Granted: 2007-03-28
Abstract: The present invention provides an automatic power restoring method capable of reliably detecting continuity by the dissolution of a line fault, to restore the optical power, even in a structure including an optical amplification medium on an optical transmission path and an optical communication system using the method. To this end, in an optical communication system to which the automatic power restoring method of the invention is applied, a pilot signal having a low transmission rate, a wavelength of which is set based on loss wavelength characteristics obtained by combining loss wavelength characteristics of an optical fiber used for the optical transmission path and loss wavelength characteristics of the optical amplification medium on the optical transmission path, is transmitted and received between an optical transmitting station and an optical receiving station when a line fault occurs, and a detection of continuity is thus performed. According to the result of the continuity detection, the power state at the occurrence of line fault is automatically restored to the power state at a time of normal operation.
Patent JP-4490652-B2 (JP)
IPC: F16K11/07
Filed: 2003-05-19
Granted: 2010-06-30
Abstract: A direct operated valve assembly (10, 210, 310) is provided including a valve body (12, 212, 312) having a pressurized inlet port (30, 230, 330) in communication with a source of pressurized air, a cylinder port (32, 232, 332), a valve bore (36, 236, 336) extending axially within the valve body, and a valve member (46, 246, 346) supported within the valve bore and movable between predetermined positions within the valve bore to selectively direct pressurized air from said inlet port through the cylinder port. An actuator (14, 214, 314) is mounted to the valve body for moving the valve member in a first direction and a biasing member (66, 266, 366) is disposed between the valve member (46, 246, 346) and the valve body (12, 212, 312) to provide a biasing force to the valve member in an opposite direction. Also, an air-assist passage (94, 294, 394) is included for providing a source of pneumatic pressure that acts in combination with the biasing member (66, 266, 366) to operatively move the valve member (46, 246, 346) in a direction opposite to the movement induced by the actuator (14, 214, 314). <IMAGE>
Patent JP-4819309-B2 (JP)
IPC: A61K9/70
Filed: 2003-10-02
Granted: 2011-11-24
Abstract: A salt (I) of a local anesthetic (preferably lidocaine) with an antiinflammatory compound (II) (preferably diclofenac) is new. (II) Is other than salicylic acid derivative. An independent claim is also included for the preparation of (I). ACTIVITY : Analgesic; Vulnerary. MECHANISM OF ACTION : None given in the source material.